Clinical Trial Update: Biomarkers of Response to Ketamine in Depression: MRI and Blood Assays Before and After Open Label Intranasal Ketamine [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial update investigating biomarkers of response to ketamine in treatment-resistant depression, using MRI and blood assays before and after open-la…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder Treatment-resistant

Snippet

Sponsor: Dan Iosifescu | Conditions: Depressive Disorder, Treatment-Resistant | Phase 2, Phase 3 | Status: COMPLETED